Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner

Adoptive cellular immunotherapy using chimeric antigen receptor (CAR)-modified T cells and Natural Killer (NK) cells are common immune cell sources administered to treat cancer patients. In detail, whereas CAR-T cells induce outstanding responses in a subset of hematological malignancies, responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Etxebeste-Mitxeltorena, Mikel, del Rincón-Loza, Inés, Martín-Antonio, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382692/
https://www.ncbi.nlm.nih.gov/pubmed/34447383
http://dx.doi.org/10.3389/fimmu.2021.717850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382692/
https://www.ncbi.nlm.nih.gov/pubmed/34447383
http://dx.doi.org/10.3389/fimmu.2021.717850

Ejemplares similares